Michal Schwartz
Department of Neurobiology
Weizmann Institute of Science
Rehovot
Israel
Name/email consistency: high
- Vaccine for the mind: Immunity against self at the choroid plexus for erasing biochemical consequences of stressful episodes. Schwartz, M., Baruch, K. Hum. Vaccin. Immunother (2012)
- "Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells? Schwartz, M. Brain Behav. Immun. (2010)
- Systemic inflammatory cells fight off neurodegenerative disease. Schwartz, M., Shechter, R. Nat. Rev. Neurol (2010)
- Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease. Schwartz, M., Shechter, R. Mol. Psychiatry (2010)
- Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Schwartz, M., London, A., Shechter, R. Neuroscience (2009)
- Immunity to self and self-maintenance: a unified theory of brain pathologies. Schwartz, M., Ziv, Y. Trends Immunol. (2008)
- Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis: the need for disease-specific approaches. Schwartz, M., Bukshpan, S., Kunis, G. BioDrugs (2008)
- Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease?. Schwartz, M., Ziv, Y. Trends Pharmacol. Sci. (2008)
- Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation. Schwartz, M., London, A. Prog. Brain Res. (2008)
- Modulating the immune system: a vaccine for glaucoma? Schwartz, M. Can. J. Ophthalmol. (2007)
- Immune-based therapy for spinal cord repair: autologous macrophages and beyond. Schwartz, M., Yoles, E. J. Neurotrauma (2006)
- Microglial phenotype: is the commitment reversible? Schwartz, M., Butovsky, O., Brück, W., Hanisch, U.K. Trends Neurosci. (2006)
- Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy. Schwartz, M., Butovsky, O., Kipnis, J. J. Neuroimmune. Pharmacol (2006)
- Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. Schwartz, M., Kipnis, J. J. Neurol. Sci. (2005)
- Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?. Schwartz, M. J. Glaucoma (2005)
- T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. Bakalash, S., Shlomo, G.B., Aloni, E., Shaked, I., Wheeler, L., Ofri, R., Schwartz, M. J. Mol. Med. (2005)
- Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells. Schwartz, M., Kipnis, J. Ann. N. Y. Acad. Sci. (2005)
- Protective autoimmunity and prospects for therapeutic vaccination against self-perpetuating neurodegeneration. Schwartz, M. Ernst Schering Res. Found. Workshop (2004)
- Optic nerve crush: protection and regeneration. Schwartz, M. Brain Res. Bull. (2004)
- A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. Schwartz, M., Kipnis, J. Trends Pharmacol. Sci. (2004)
- Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity. Schwartz, M., Kipnis, J. Cell. Mol. Life Sci. (2004)
- Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture. Schwartz, M. Invest. Ophthalmol. Vis. Sci. (2003)
- Macrophages and microglia in central nervous system injury: are they helpful or harmful?. Schwartz, M. J. Cereb. Blood Flow Metab. (2003)
- Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches. Schwartz, M. Eur. J. Ophthalmol (2003)
- Protective autoimmunity against the enemy within: fighting glutamate toxicity. Schwartz, M., Shaked, I., Fisher, J., Mizrahi, T., Schori, H. Trends Neurosci. (2003)
- Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift. Schwartz, M., Kipnis, J. Neuroscientist (2002)
- Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'. Schwartz, M., Kipnis, J. Trends Immunol. (2002)
- T cell-based therapeutic vaccination for spinal cord injury. Schwartz, M., Hauben, E. Prog. Brain Res. (2002)
- Beneficial immune activity after CNS injury: prospects for vaccination. Schwartz, M., Moalem, G. J. Neuroimmunol. (2001)
- T cell mediated neuroprotection is a physiological response to central nervous system insults. Schwartz, M. J. Mol. Med. (2001)
- Physiological approaches to neuroprotection. boosting of protective autoimmunity. Schwartz, M. Surv. Ophthalmol (2001)
- Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Schwartz, M., Kipnis, J. Trends. Mol. Med (2001)
- Immunological approaches to the treatment of spinal cord injury. Schwartz, M. BioDrugs (2001)
- Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches. Schwartz, M. Eur. J. Ophthalmol (2001)
- Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Schwartz, M. Prog. Neurobiol. (2001)
- Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders. Schwartz, M. Cell. Mol. Neurobiol. (2001)
